Effect of Diabetic Neuropathy on Reparative Ability and Immune Response System
- PMID: 37523019
- DOI: 10.1007/s12033-023-00813-z
Effect of Diabetic Neuropathy on Reparative Ability and Immune Response System
Abstract
The effects of diabetes can be divided into short, medium and long term and various human organ systems can be effected. The present study aimed to determine how much the duration of diabetes mellitus (DM) affect the reparative ability of the body, immune response and the development of DM complications. Interleukin 1-β (IL-1β) and Interleukin 6 (IL-6) were monitored as specific indicators of inflammatory reaction and C-reactive protein (CRP), leukocyte count (WBC) and sedimentation rate (ESR) as general markers of inflammatory reaction. Tumour necrosis factor α (TNF-α) and transforming growth factor β1 (TGF-β1) were observed as indicators of reparative ability and polyneuropathy. All interleukins were determined by ELISA and evaluated spectrophotometrically. Michigan Neuropathy Screening Instrument (MNSI) is performed for neuropathy examination. Patients with diabetes mellitus were divided into 3 groups, according to duration of diabetes mellitus. IL-6 levels correlated with clinical stage of diabetic polyneuropathy at p = 0.025 R = 0.402; with CRP at p = 0.0001, R = 0.784 as well as correlation of CRP and MNSI score (R = 0.500, p = 0.034) in a group of patients with DM lasting up to 10 years. The reparative ability of the body is reduced by physiological age and ages of DM duration. The immune response is weakened in DM additionally. The dual activity of cytokines IL-6 and TGF-β1 is present in long-duration Diabetes Mellitus.
Keywords: Cytokines; Diabetic polyneuropathy; Immune response; Long-term effects of DM; Neuroimmunology; Reparative ability.
© 2023. The Author(s).
Similar articles
-
Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.Folia Med (Plovdiv). 2011 Apr-Jun;53(2):44-50. doi: 10.2478/v10153-010-0036-8. Folia Med (Plovdiv). 2011. PMID: 21797106
-
Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy.Med Glas (Zenica). 2021 Feb 1;18(1):12-17. doi: 10.17392/1279-21. Med Glas (Zenica). 2021. PMID: 33480229
-
Diabetic Polyneuropathy in Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study.Cureus. 2022 Oct 6;14(10):e30004. doi: 10.7759/cureus.30004. eCollection 2022 Oct. Cureus. 2022. PMID: 36348847 Free PMC article.
-
Turkish version of the Michigan Neuropathy Screening Instrument in the assessment of diabetic peripheral neuropathy: a validity and reliability study.Diabetol Int. 2020 Feb 21;11(3):283-292. doi: 10.1007/s13340-020-00427-9. eCollection 2020 Jul. Diabetol Int. 2020. PMID: 32802710 Free PMC article.
-
Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.Cytokine. 2016 Oct;86:100-109. doi: 10.1016/j.cyto.2016.06.028. Epub 2016 Aug 4. Cytokine. 2016. PMID: 27498215 Review.
Cited by
-
Protein Supplementation May Dampen Positive Effects of Exercise on Glucose Homeostasis: A Pilot Weight Loss Intervention.Nutrients. 2023 Nov 29;15(23):4947. doi: 10.3390/nu15234947. Nutrients. 2023. PMID: 38068805 Free PMC article.
-
Unraveling the Role of Tumor Necrosis Factor-Alpha in Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.Cureus. 2023 Dec 4;15(12):e49926. doi: 10.7759/cureus.49926. eCollection 2023 Dec. Cureus. 2023. PMID: 38179375 Free PMC article. Review.
-
The Relationship Between UA/HDL and Diabetic Peripheral Neuropathy: A Cross-Sectional Analysis.Diabetes Metab Syndr Obes. 2024 Feb 27;17:969-980. doi: 10.2147/DMSO.S447809. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38435629 Free PMC article.
-
Protective role of SIRT1 (rs3758391 T > C) polymorphism against T2DM and its complications: Influence on GPx activity.Health Sci Rep. 2024 Oct 28;7(11):e70106. doi: 10.1002/hsr2.70106. eCollection 2024 Nov. Health Sci Rep. 2024. PMID: 39474345 Free PMC article.
-
Formate Might Be a Novel Potential Serum Metabolic Biomarker for Type 2 Diabetic Peripheral Neuropathy.Diabetes Metab Syndr Obes. 2023 Oct 10;16:3147-3160. doi: 10.2147/DMSO.S428933. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37842336 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous